{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T23:10:35Z","timestamp":1777936235956,"version":"3.51.4"},"reference-count":19,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Magnetic Resonance Imaging"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1016\/j.mri.2012.01.004","type":"journal-article","created":{"date-parts":[[2012,3,27]],"date-time":"2012-03-27T17:19:22Z","timestamp":1332868762000},"page":"689-693","source":"Crossref","is-referenced-by-count":45,"title":["Potential clinical factors affecting hepatobiliary enhancement at Gd-EOB-DTPA-enhanced MR imaging"],"prefix":"10.1016","volume":"30","author":[{"given":"Atsushi","family":"Higaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsutomu","family":"Tamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teruki","family":"Sone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiko","family":"Kanki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiro","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daigo","family":"Tanimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Higashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuyoshi","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mri.2012.01.004_bb0005","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1148\/radiology.200.1.8657946","article-title":"Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA","volume":"200","author":"Vogl","year":"1996","journal-title":"Radiology"},{"key":"10.1016\/j.mri.2012.01.004_bb0010","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s003300050150","article-title":"Enhancement characteristics of liver metastases, hepatocellular carcinomas, and hemangiomas with Gd-EOB-DTPA: preliminary results with dynamic MR imaging","volume":"7","author":"Reimer","year":"1997","journal-title":"Eur Radiol"},{"key":"10.1016\/j.mri.2012.01.004_bb0015","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/mrm.1910220214","article-title":"A new lipophilic gadolinium chelate as a tissue-specific contrast medium for MRI","volume":"22","author":"Weinmann","year":"1991","journal-title":"Magn Reson Med"},{"key":"10.1016\/j.mri.2012.01.004_bb0020","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1148\/radiology.183.1.1549695","article-title":"Preclinical evaluation of Gd-EOB-DTPA as a contrast agent in MR imaging of the hepatobiliary system","volume":"183","author":"Schuhmann-Giampieri","year":"1992","journal-title":"Radiology"},{"key":"10.1016\/j.mri.2012.01.004_bb0025","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1097\/00004424-199208000-00010","article-title":"Gadolinium-ethoxybenzyl-DTPA, a new liver-specific magnetic resonance contrast agent. Kinetic and enhancement patterns in normal and cholestatic rats","volume":"27","author":"Cl\u00e9ment","year":"1992","journal-title":"Invest Radiol"},{"key":"10.1016\/j.mri.2012.01.004_bb0030","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S1064-9689(21)00554-7","article-title":"Liver. III: gadolinium-based hepatobiliary contrast agents (Gd-EOB-DTPA and Gd-BOPTA\/Dimeg)","volume":"4","author":"Giovagnoni","year":"1996","journal-title":"Magn Reson Imaging Clin N Am"},{"key":"10.1016\/j.mri.2012.01.004_bb0035","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1007\/s00330-008-0929-6","article-title":"Contrast-enhanced MR cholangiography with Gd-EOB-DTPA in patients with liver cirrhosis: visualization of the biliary ducts in comparison with patients with normal liver parenchyma","volume":"18","author":"Tschirch","year":"2008","journal-title":"Eur Radiol"},{"key":"10.1016\/j.mri.2012.01.004_bb0040","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3348\/kjr.2004.5.4.231","article-title":"Quantitative evaluation of liver function with MRI Using Gd-EOB-DTPA","volume":"5","author":"Ryeom","year":"2004","journal-title":"Korean J Radiol"},{"key":"10.1016\/j.mri.2012.01.004_bb0045","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1002\/jmri.21956","article-title":"Liver parenchymal enhancement of hepatocyte-phase images in Gd-EOB-DTPA-enhanced MR imaging: which biological markers of the liver function affect the enhancement?","volume":"30","author":"Motosugi","year":"2009","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.mri.2012.01.004_bb0050","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1002\/jmri.1880070413","article-title":"Experimental hepatic dysfunction: evaluation by MRI with Gd-EOB-DTPA","volume":"7","author":"Kim","year":"1997","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.mri.2012.01.004_bb0055","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1124\/dmd.110.032862","article-title":"Hepatic uptake of the magnetic resonance imaging contrast agent Gd-EOB-DTPA: role of human organic anion transporters","volume":"38","author":"Leonhardt","year":"2010","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.mri.2012.01.004_bb0060","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0022-3565(24)34879-7","article-title":"Hepatic uptake of the magnetic resonance imaging contrast agent gadoxetate by the organic anion transporting polypeptide Oatp1","volume":"290","author":"van Montfoort","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.mri.2012.01.004_bb0065","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s00535-009-0056-4","article-title":"Expression of OATP1B3 determines uptake of Gd-EOB-DTPA in hepatocellular carcinoma","volume":"44","author":"Narita","year":"2009","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.mri.2012.01.004_bb0070","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1111\/j.1440-1681.2007.04798.x","article-title":"OATP1B1 polymorphism is a major determinant of serum bilirubin level but not associated with rifampicin-mediated bilirubin elevation","volume":"34","author":"Zhang","year":"2007","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.mri.2012.01.004_bb0075","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1080\/00498250801986951","article-title":"Xenobiotic transporters of the human organic anion transporting polypeptides (OATP) family","volume":"38","author":"Hagenbuch","year":"2008","journal-title":"Xenobiotica"},{"key":"10.1016\/j.mri.2012.01.004_bb0080","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1007\/s00210-006-0040-y","article-title":"Pharmacogenomics of human OATP transporters","volume":"372","author":"K\u00f6nig","year":"2006","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.mri.2012.01.004_bb0085","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1053\/jhep.2003.50317","article-title":"Effects of proinflammatory cytokines on rat organic anion transporters during toxic liver injury and cholestasis","volume":"38","author":"Geier","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.mri.2012.01.004_bb0090","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S0168-8278(02)00108-3","article-title":"Hepatobiliary organic anion transporters are differentially regulated in acute toxic liver injury induced by carbon tetrachloride","volume":"37","author":"Geier","year":"2002","journal-title":"J Hepatol"},{"key":"10.1016\/j.mri.2012.01.004_bb0095","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/01.rli.0000154587.00638.77","article-title":"Magnetic resonance imaging with hepatospecific contrast agents in cirrhotic rat livers","volume":"40","author":"Planchamp","year":"2005","journal-title":"Invest Radiol"}],"container-title":["Magnetic Resonance Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0730725X12000409?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0730725X12000409?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T03:27:49Z","timestamp":1742786869000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0730725X12000409"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":19,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S0730725X12000409"],"URL":"https:\/\/doi.org\/10.1016\/j.mri.2012.01.004","relation":{},"ISSN":["0730-725X"],"issn-type":[{"value":"0730-725X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]}}}